Clinical Updates & Insights

Clinical Update

Shape-Sensing Robotic-Assisted Bronchoscopy May Improve Diagnostic Efficiency, Shorten Time to Treatment for Patients with Malignant Lung Lesions

• Wednesday, November 24, 2021

Clinical Update

Multimodality Care Is Improving Survival for Patients with Melanoma Brain Metastasis

Overall survival (OS) for patients with melanoma brain metastasis treated at Memorial Sloan Kettering Cancer Center has increased significantly over the past five years, up to 13 months, according to our research published recently in Cancer.

• Thursday, November 18, 2021

Clinical Update

A Milestone for Precision Oncology: FDA Gives Green Light to MSK’s Genetic Database

OncoKB, a database developed and maintained by investigators at MSK, helps match patients with targeted therapies based on the mutations found in their tumors.

• Thursday, November 4, 2021

Clinical Update

ASTRO 2021: New Study from Memorial Sloan Kettering Cancer Center Finds Targeted Radiation Beneficial in Cases of Advanced Lung Cancer

• Sunday, October 24, 2021

Clinical Update

Shorter time to stereotactic radiosurgery after brain metastases resection improves patient outcomes

Local control rates and overall survival (OS) were significantly higher for patients with brain metastases treated with adjuvant stereotactic radiosurgery (SRS) within two months of resection, compared to longer time intervals, according to our new study published recently in Neuro-Oncology Practice.

• Thursday, September 23, 2021

Clinical Update

International Clinical Trial Delivers Promising Results of HER2-Targeted Therapy for Non-Small Cell Lung Cancer

New data published in the New England Journal of Medicine (NEJM) and featured at the European Society for Medical Oncology (ESMO) Congress 2021 highlights a promising new treatment for individuals with HER2-mutant non-small cell lung cancer (NSCLC).

• Saturday, September 18, 2021

Clinical Update

Including AYA Patients in Cancer Clinical Trials

MSK physicians and researchers design and conduct clinical trials that include adolescent and young adult (AYA) cancer patients, ensuring they are not lost between the typical siloes of adult and pediatric cancer trials.

• Monday, September 13, 2021

Clinical Update

When Tailoring Cancer Treatment, Biology Matters More than Age

Early-onset colorectal cancer (CRC) is likely clinically and genomically indistinguishable from average-onset cancer, according to a recent study published in the Journal of the National Cancer Institute by MSK investigators.

• Monday, September 13, 2021

Clinical Update

Altered Mental Status in Cancer Patients after COVID-19 Driven by “Cytokine Storm” in CSF

MSK research team identifies unique markers of inflammation and neurodegeneration found in cerebrospinal fluid of cancer patients with altered mental status after initial SARS-CoV-2 infection, as likely cause of neurologic dysfunction.

• Tuesday, March 2, 2021

Clinical Update

Minimally Invasive Surgery of Right Superior Liver Segments Safe and Effective

Minimally invasive surgery (MIS) to resect liver segments 7 and 8 is safe for select patients treated by experienced MIS hepatopancreatobiliary surgeons.

• Tuesday, March 2, 2021